摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(di-(t-butoxycarbonyl)amino)pyridazine | 264600-84-2

中文名称
——
中文别名
——
英文名称
3-(di-(t-butoxycarbonyl)amino)pyridazine
英文别名
tert-butyl N-[(2-methylpropan-2-yl)oxycarbonyl]-N-pyridazin-3-ylcarbamate
3-(di-(t-butoxycarbonyl)amino)pyridazine化学式
CAS
264600-84-2
化学式
C14H21N3O4
mdl
——
分子量
295.338
InChiKey
QXTRFPWYATVJIM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    21
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    81.6
  • 氢给体数:
    0
  • 氢受体数:
    6

文献信息

  • Heterocyclylaminomethyloxazo-lidinones as antibacterials
    申请人:AstraZeneca AB
    公开号:US20030207899A1
    公开(公告)日:2003-11-06
    Compounds of formula (I) 1 , or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof, wherein, for example, HET is an optionally substituted C-linked 5-membered heteroaryl ring containing 2 to 4 heteroatoms independently selected from N, O and S; Q is selected from, for example, Q3 and Q5; R 2 and R 3 are independently hydrogen or fluoro; T is selected from a range of groups, for example, an N-linked (fully unsaturated) 5-membered heteroaryl ring system or a group of formula (TC5): wherein Rc is, for example, R 13 CO—, R 13 SO 2 — or R 13 CS—; wherein R 13 is, for example, optionally substituted (1-10C)alkyl or R 14 C(O)O(1-6C)alkyl wherein R 14 is optionally substituted (1-10C)alkyl; are useful as antibacterial agents; and processes for their manufacture and pharmaceutical compositions containing them are described.
    化合物的公式(I)1,或其药用盐,或其体内可解酯,其中,例如,HET是一个含有2到4个异原子(N、O和S)的可选择取代的C-连接的5元杂环芳烃环;Q可以从Q3和Q5中选择;R2和R3独立地为氢或;T可以从一系列基团中选择,例如,一个N-连接的(完全不饱和的)5元杂环芳烃环系统或一个公式(TC5)的基团:其中Rc是,例如,R13CO—,R13SO2—或R13CS—;其中R13是,例如,可选择取代的(1-10C)烷基或R14C(O)O(1-6C)烷基,其中R14是可选择取代的(1-10C)烷基;作为抗菌剂是有用的;并描述了它们的制备方法和含有它们的药物组合物。
  • HETEROCYCLYLAMINOMETHYLOXAZOLIDINONES AS ANTIBACTERIALS
    申请人:AstraZeneca AB
    公开号:EP1121358A1
    公开(公告)日:2001-08-08
  • US6734200B1
    申请人:——
    公开号:US6734200B1
    公开(公告)日:2004-05-11
  • US7087629B2
    申请人:——
    公开号:US7087629B2
    公开(公告)日:2006-08-08
  • [EN] HETEROCYCLYL AMINO METHYLOXA ZOLIDINONES AS ANTIBACTERIALS<br/>[FR] HETEROCYCLYL AMINO METHYLOXA ZOLIDINONES COMME AGENTS ANTIBACTERIENS
    申请人:ZENECA LTD
    公开号:WO2000021960A1
    公开(公告)日:2000-04-20
    Compounds of formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof, wherein, for example, HET is an optionally substituted C-linked 5-membered heteroaryl ring containing 2 to 4 heteroatoms independently selected from N, O and S; Q is selected from, for example, Q1 and Q2: R?2 and R3¿ are independently hydrogen or fluoro; T is selected from a range of groups, for example, an N-linked (fully unsaturated) 5-membered heteroaryl ring system or a group of formula (TC5): wherein Rc is, for example, R?13CO-, R13SO¿2- or R13CS-; wherein R13 is, for example, optionally substituted (1-10C)alkyl or R14C(O)O(1-6C)alkyl wherein R14 is optionally substituted (1-10C)alkyl; are useful as antibacterial agents; and processes for their manufacture and pharmaceutical compositions containing them are described.
查看更多